YB-1 immunization combined with regulatory T-cell depletion induces specific T-cell responses that protect against neuroblastoma in the early stage

Zheng, Jin; Liu, Ping; Yang, Xiaofeng
December 2012
Acta Biochimica et Biophysica Sinica;Dec2012, Vol. 44 Issue 12, p1006
Academic Journal
Neuroblastoma is the most common extracranial solid cancer in childhood and the most common cancer in infancy. Currently, no effective clinical treatments are available for advanced neuroblastoma. In a previous study, we screened Y Box protein 1 (YB-1) as a potential neuroblastoma-associated antigen from sera of AGN2a-immunized mice by serological analysis of recombinant cDNA expression libraries technique. The aim of this study is to explore if YB-1 immunization in the context of Treg depletion could induce protective immune response against the neuroblastoma in mice. YB-1 was expressed and purified by pET-15b prokaryotic expression system. It was demonstrated that anti-YB-1 CD8+ T-cell responses could be induced by AGN2a immunization, and the strongest CD8+ T-cell responses against AGN2a were induced by YB-1-immunized mice in the context of Treg depletion compared with YB-1 only immunization group and control group. Importantly, the survival rate of mice treated with YB-1 immunization combined with Treg depletion was 80% when challenged by 1 × 104 AGN2a cells, significantly higher than that of mice immunized with YB-1 alone (P < 0.01). Furthermore, T-cell adoptive therapy showed that the neuroblastoma growth was inhibited when T cells or splenic cells from YB-1-immunized mice with Treg depletion were transferred to AGN2a bearing mice. Both CD4+ and CD8+ T cells were involved in the anti-neuroblastoma responses induced by YB-1 immunization combined with Treg depletion. These results indicated that YB-1 immunization combined with Treg depletion could induce specific T-cell responses against neuroblastoma and could be a potential strategy for the prevention and treatment of neuroblastoma in the early stage.


Related Articles

  • Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. Munier, M L; Kelleher, A D // Immunology & Cell Biology;Jan2007, Vol. 85 Issue 1, p6 

    Human immunodeficiency virus (HIV) infection causes chronic progressive immunodeficiency and immune dysregulaton. Although simple depletion of the major target of HIV infection, the CD4+ T cell, can explain much of the immunosuppression seen, there are multiple other factors contributing to the...

  • Escape of malaria parasites from host immunity requires CD4+CD25+ regulatory T cells. Hisaeda, Hajime; Maekawa, Yoichi; Daiji Iwakawa, Yoichi; Hiroko Okada; Kunisuke Himeno, Yoichi; Kenji Kishihara; Shin-ichi Tsukumo; Koji Yasutomo // Nature Medicine;Jan2004, Vol. 10 Issue 1, p29 

    Infection with malaria parasites frequently induces total immune suppression, which makes it difficult for the host to maintain long-lasting immunity. Here we show that depletion of CD4+CD25+ regulatory T cells (Treg) protects mice from death when infected with a lethal strain of Plasmodium...

  • Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells. Urbanska, Katarzyna; Lynn, Rachel L.; Stashwick, Caitlin; Thakur, Archana; Lum, Lawrence G.; Powell Jr., Daniel J. // Journal of Translational Medicine;2014, Vol. 12 Issue 1, p414 

    Background Redirection of T lymphocytes against tumor antigens can induce dramatic regression of advanced stage malignancy. The use of bispecific antibodies (BsAbs) that bind both the Tcell receptor (TCR) and a target antigen is one promising approach to T-cell redirection. However, BsAbs...

  • CSP-A Model for In Vivo Presentation of Plasmodium berghei Sporozoite Antigens by Hepatocytes. Balam, Saidou; Romero, Jackeline F.; Bongfen, Silayuv E.; Guillaume, Philippe; Corradin, Giampietro // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    One target of protective immunity against the Plasmodium liver stage in BALB/c mice is represented by the circumsporozoite protein (CSP), and mainly involves its recognition by IFN-γ producing specific CD8+T-cells. In a previous in vitro study we showed that primary hepatocytes from BALB/c...

  • CD28/CD154 Blockade Prevents Autoimmune Diabetes by Inducing Nondeletional Tolerance After Effector T-Cell Inhibition and Regulatory T-Cell Expansion. Rigby, Mark R.; Trexler, Alison M.; Pearson, Thomas C.; Larsen, Christian P. // Diabetes;Oct2008, Vol. 57 Issue 10, p2672 

    OBJECTIVE--Blocking T-cell signaling is an effective means to prevent autoimmunity and allograft rejection in many animal models, yet the clinical translation of many of these approaches has not resulted in the success witnessed in experimental systems. Improved understanding of these approaches...

  • Heavy functions for light chains. Röcken, Martin; Hültner, Lothar // Nature Medicine;Jul2002, Vol. 8 Issue 7, p668 

    Reports on the identification of early signs required to recruit memory T cells to sites of antigen-specific inflammation. Benefits of the T-cell responses in protection against pathogens; Investigation of the early steps of immune response; Benefits of the findings in understanding various...

  • TLR2- and Dectin 1-Associated Innate Immune Response Modulates T-Cell Response to Pancreatic β-Cell Antigen and Prevents Type 1 Diabetes. Karumuthil-Melethil, Subha; Sofi, M. Hanief; Gudi, Radhika; Johnson, Benjamin M.; Perez, Nicolas; Vasu, Chenthamarakshan // Diabetes;Apr2015, Vol. 64 Issue 4, p1341 

    The progression of autoimmune diseases is dictated by deviations in the fine balance between proinflammatory versus regulatory responses, and pathogen recognition receptors (PRRs) play a key role in maintaining this balance. Previously, we have reported that ligation of Toll-like receptor 2...

  • The targeting of immunosuppressive mechanisms in hematological malignancies. Andersen, M H // Leukemia (08876924);Sep2014, Vol. 28 Issue 9, p1784 

    The adaptive immune system has the capacity to recognize and kill leukemic cells. However, immune tolerance mechanisms that normally protect healthy tissues from autoimmune effects prevent the development of effective antitumor immunity. Tumors use several different immunosuppressive mechanisms...

  • Tumor-specific CD4 T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells. Akhmetzyanova, Ilseyar; Zelinskyy, Gennadiy; Schimmer, Simone; Brandau, Sven; Altenhoff, Petra; Sparwasser, Tim; Dittmer, Ulf // Cancer Immunology, Immunotherapy;Feb2013, Vol. 62 Issue 2, p257 

    The important role of tumor-specific cytotoxic CD8 T cells is well defined in the immune control of the tumors, but the role of effector CD4 T cells is poorly understood. In the current research, we have used a murine retrovirus-induced tumor cell line of C57BL/6 mouse origin, namely FBL-3...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics